Clinical trial
Azithromycin in Combination With Chloroquine Versus Chloroquine in the…
NCT00082563 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00082563 |
|---|---|
| Title | Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum |
| Official title | A Phase II, Randomized, Comparative Trial Of Azithromycin In Combination With Chloroquine Versus Chloroquine In The Eradication Of Asymptomatic Plasmodium Falciparum Infection In Semi-Immune Adults |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | Azithromycin/Chloroquine, Chloroquine |
| Enrollment | 14 |
| Start date | Aug 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | May 14, 2004 |
| Last update posted | Apr 26, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: